FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2541569149> ?p ?o ?g. }

• W2541569149 endingPage "83039" @default.
• W2541569149 startingPage "83031" @default.
• W2541569149 abstract "// Jie Gao 1, * , Linting Wei 1, * , Jiali Wei 2 , Ganglian Yao 1 , Li Wang 1 , Meng Wang 3 , Xinghan Liu 3 , Cong Dai 3 , Tianbo Jin 4 , Zhijun Dai 3 , Rongguo Fu 1 1 Department of Nephrology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China 2 Department of Nephrology, Hainan general hospital, Haikou 570311, China 3 Department of Oncology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China 4 National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University, Xi’an 710069, China * These authors have contributed equally to this work Correspondence to: Jie Gao, email: gxej_cn@sina.com Rongguo Fu, email: pipifu@126.com Keywords: toll-like receptor 1, IgAN, single nucleotide polymorphism, susceptibility, case-control study Received: July 25, 2016     Accepted: October 12, 2016     Published: October 28, 2016 ABSTRACT Toll-like receptors (TLRs) are a family of transmembrane receptors, and play a vital role in recognizing invading pathogens and activating innate immunity. Previous studies indicated that TLR1 single nucleotide polymorphisms (SNPs) might be associated with the risk of IgA nephropathy (IgAN). This study aims to investigate the relationship between TLR1 SNPs (rs4833095 and rs5743557) and IgAN in a Chinese Han population. This case-control study included 351 patients with IgAN and 310 healthy controls. Two SNPs (rs4833095 and rs5743557) of TLR1 were genotyped by Sequenom MassARRAY. Odds ratios (OR) with 95% confidence intervals (CI) were used to assess the relationship with IgAN. We found that both allele and genotype frequencies of rs5743557 were not associated with IgAN risk. Rs4833095 increased IgAN risk compared with controls in the allele, dominant and log-additive models ( P = 0.04, 0.04 and 0.03, respectively). Further haplotype analysis revealed that the T rs4833095 T rs5743557 haplotype may be a risk factor for IgAN (OR = 1.28; 95% CI = 1.01–1.63; P = 0.046). Furthermore, rs4833095 was associated with Lee’s grades (OR = 1.75; 95% CI = 1.03–2.96; P = 0.04). However, there was no significant association between the genotype distributions of rs5743557 and clinical parameters of IgAN such as gender, 24 hour urine protein, blood pressure, and Lee’s grades. Taken together, these findings suggest that the TLR1 rs4833095 polymorphism may play a role in the development and progression of IgAN." @default.
• W2541569149 created "2016-11-04" @default.
• W2541569149 creator A5001514460 @default.
• W2541569149 creator A5005119736 @default.
• W2541569149 creator A5012278873 @default.
• W2541569149 creator A5022731359 @default.
• W2541569149 creator A5025550930 @default.
• W2541569149 creator A5035460630 @default.
• W2541569149 creator A5036015998 @default.
• W2541569149 creator A5036726873 @default.
• W2541569149 creator A5051827309 @default.
• W2541569149 creator A5065956787 @default.
• W2541569149 creator A5081012496 @default.
• W2541569149 date "2016-10-28" @default.
• W2541569149 modified "2023-09-22" @default.
• W2541569149 title "<i>TLR1</i> polymorphism rs4833095 as a risk factor for IgA nephropathy in a Chinese Han population: A case-control study" @default.
• W2541569149 cites W1655860314 @default.
• W2541569149 cites W1709885097 @default.
• W2541569149 cites W1975178331 @default.
• W2541569149 cites W1975275391 @default.
• W2541569149 cites W1989464452 @default.
• W2541569149 cites W1991448856 @default.
• W2541569149 cites W1993857686 @default.
• W2541569149 cites W1995744610 @default.
• W2541569149 cites W2000189931 @default.
• W2541569149 cites W2016862474 @default.
• W2541569149 cites W2042433863 @default.
• W2541569149 cites W2049319531 @default.
• W2541569149 cites W2058486613 @default.
• W2541569149 cites W2077851831 @default.
• W2541569149 cites W2089877898 @default.
• W2541569149 cites W2105617732 @default.
• W2541569149 cites W2114216755 @default.
• W2541569149 cites W2126626660 @default.
• W2541569149 cites W2132507498 @default.
• W2541569149 cites W2133449490 @default.
• W2541569149 cites W2135239485 @default.
• W2541569149 cites W2140006882 @default.
• W2541569149 cites W2142672161 @default.
• W2541569149 cites W2147100699 @default.
• W2541569149 cites W2148579227 @default.
• W2541569149 cites W2153540429 @default.
• W2541569149 cites W2167262253 @default.
• W2541569149 cites W2175687902 @default.
• W2541569149 cites W2195582449 @default.
• W2541569149 cites W2233843360 @default.
• W2541569149 cites W2305164061 @default.
• W2541569149 cites W2410572648 @default.
• W2541569149 cites W2514938837 @default.
• W2541569149 cites W4247172809 @default.
• W2541569149 doi "https://doi.org/10.18632/oncotarget.12965" @default.
• W2541569149 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5347750" @default.
• W2541569149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27806314" @default.
• W2541569149 hasPublicationYear "2016" @default.
• W2541569149 type Work @default.
• W2541569149 sameAs 2541569149 @default.
• W2541569149 citedByCount "10" @default.
• W2541569149 countsByYear W25415691492017 @default.
• W2541569149 countsByYear W25415691492019 @default.
• W2541569149 countsByYear W25415691492020 @default.
• W2541569149 countsByYear W25415691492021 @default.
• W2541569149 countsByYear W25415691492022 @default.
• W2541569149 crossrefType "journal-article" @default.
• W2541569149 hasAuthorship W2541569149A5001514460 @default.
• W2541569149 hasAuthorship W2541569149A5005119736 @default.
• W2541569149 hasAuthorship W2541569149A5012278873 @default.
• W2541569149 hasAuthorship W2541569149A5022731359 @default.
• W2541569149 hasAuthorship W2541569149A5025550930 @default.
• W2541569149 hasAuthorship W2541569149A5035460630 @default.
• W2541569149 hasAuthorship W2541569149A5036015998 @default.
• W2541569149 hasAuthorship W2541569149A5036726873 @default.
• W2541569149 hasAuthorship W2541569149A5051827309 @default.
• W2541569149 hasAuthorship W2541569149A5065956787 @default.
• W2541569149 hasAuthorship W2541569149A5081012496 @default.
• W2541569149 hasBestOaLocation W25415691491 @default.
• W2541569149 hasConcept C104317684 @default.
• W2541569149 hasConcept C126322002 @default.
• W2541569149 hasConcept C135763542 @default.
• W2541569149 hasConcept C143998085 @default.
• W2541569149 hasConcept C146304588 @default.
• W2541569149 hasConcept C153209595 @default.
• W2541569149 hasConcept C156957248 @default.
• W2541569149 hasConcept C203014093 @default.
• W2541569149 hasConcept C2908647359 @default.
• W2541569149 hasConcept C54355233 @default.
• W2541569149 hasConcept C71924100 @default.
• W2541569149 hasConcept C86803240 @default.
• W2541569149 hasConcept C99454951 @default.
• W2541569149 hasConceptScore W2541569149C104317684 @default.
• W2541569149 hasConceptScore W2541569149C126322002 @default.
• W2541569149 hasConceptScore W2541569149C135763542 @default.
• W2541569149 hasConceptScore W2541569149C143998085 @default.
• W2541569149 hasConceptScore W2541569149C146304588 @default.
• W2541569149 hasConceptScore W2541569149C153209595 @default.
• W2541569149 hasConceptScore W2541569149C156957248 @default.
• W2541569149 hasConceptScore W2541569149C203014093 @default.
• W2541569149 hasConceptScore W2541569149C2908647359 @default.
• W2541569149 hasConceptScore W2541569149C54355233 @default.

• next